Group B streptococcal (GBS) tricuspid infective endocarditis is a very rare clinical entity. It affects intravenous drug users, pregnant, postpartum women, and the elderly. We report the case of a 68-year-old patient without known predisposing factors who presented a GBS tricuspid endocarditis treated by penicillin and aminoglycosides with no response. The patient was operated with a good evolution. Our case is the 25th reported in the literature. GBS disease is increasing in the elderly and is mainly associated to comorbid conditions. Tricuspid infective endocarditis with Group B streptococcus predominantly presents as a persistent fever with respiratory symptoms due to pulmonary embolism. Therefore, it requires a medicosurgical treatment and close follow-up. 
Introduction
R ight-sided infective endocarditis (RSIE) is a rare clinical entity that occurs predominantly in intravenous drug users and involves mainly the tricuspid valve [1] . Pathogenesis, clinical features, and prognosis of RSIE occurring in nondrug users are not well known [2] . In fact, there are only a few studies on RSIE in nondrug users without human immunodeficiency virus infection. Staphylococcus aureus is the most common microbiological pathogen. Other causes of RSIE include coagulase-negative staphylococci and streptococci [3, 4] . Group B Streptococcus (Streptococcus agalactiae) is a b-hemolytic Gram-positive bacterium [5] . This pathogen is a member of the genitourinary female tract and gastrointestinal normal flora in some humans [5] . S. agalactiae is one of the major causes of neonatal bacterial 
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Disclosure: Authors have nothing to disclose with regard to commercial support. septicemia and meningitis [6] . Group B streptococcal disease (GBS), once rare in adults, is actually in perpetual increase, especially in the elderly [7] . However, GBS infective endocarditis remains a rare clinical entity (3% of GBS invasive infections) [7] . It mainly affects the left-sided heart valves and rarely the tricuspid valve [8] . In this paper we report the case of an elderly patient without known comorbidities who presented with tricuspid endocarditis due to S. agalactiae. The pathophysiology, clinical features, and therapeutic options are reviewed.
Case report
A 68-year-old man was admitted with prolonged fever, arthralgia, headache, and asthenia of 3 weeks' duration. The patient had no history of cardiovascular disease or illicit drugs abuse. There was no notion of recent hospitalization or intravenous catheter placement. On admission, the patient was pale with dyspnea at rest. On examination, his temperature, blood pressure, pulse, respiratory rate, and oxygen saturation while breathing room air were, respectively: 39.2°C; 115/70 mmHg; 96 beats/min; 24 breaths/min; and 96%. Auscultation of lung fields was normal. Cardiac auscultation revealed a systolic murmur at the left lower sternal border increasing with inspiration. Physical examination revealed jugular veins distension with a hepatojugular reflux and a mild painful hepatomegaly. The electrocardiogram showed a sinus tachycardia. Chest X-ray revealed a mild cardiomegaly. Laboratory tests revealed leukocytosis of 13.2 Â 10 9 , anemia with hemoglobin of 9.3 g/dL, erythrocyte sedimentation rate of 90 mm/h, and C-reactive protein of 260 mg/L. On transthoracic and transesophageal echocardiography, there was a large, mobile, and pedunculated vegetation measuring 15 mm Â 10 mm attached to the anterior tricuspid valve with severe regurgitation (Fig. 1 ) and severe pulmonary hypertension (systolic pulmonary arterial pressure = 55 mmHg). The right ventricle had normal size and function (tricuspid annular plane systolic excursion = 25 mm; S wave = 13 cm/s). The left ventricle and aortic and mitral valves were normal. The diagnosis of right-sided infective endocarditis was made. Treatment with vancomycin and gentamycin was started after several blood culture series and urine analysis. There were no organisms in the urine. S. agalactiae was isolated in three blood cultures. Since this bacterium was sensitive to penicillin and aminoglycosides, vancomycin was stopped and changed to penicillin. Abdominal and cerebral CT scans were normal. Human immunodeficiency virus and tumor markers were negative and digestive exploration including colonoscopy was normal. After 2 weeks with appropriate antibiotic treatment, the patient complained of fever and dyspnea. A ventilation-perfusion lung scan showed matched ventilation and perfusion defect at the lingual secondary to septic pulmonary embolism. A control transesophageal echocardiography revealed a further increase in the vegetation of the tricuspid valve and there was no inflammatory resolution: C-reactive protein rate remained 180 mg/L after an initial decrease. Medical treatment was changed again to daily vancomycin, gentamycin, and rifampicin and the patient underwent surgery. Large vegetation was attached to the tricuspid valve (Fig. 2) . The surgery had consisted at a resection of the vegetation, tricuspid valve repair and annuloplasty with a Carpentier-Edwards ring No. 28. The postoperative course was uneventful. Control transthoracic echocardiography revealed a mild tricuspid regurgitation without residual vegetation (Fig. 3) . Bacteriological analysis of the vegetation revealed the presence of neutrophils and organisms. Antibiotics were continued until 6 weeks, and the patient was discharged after total clinical and biological recovery. The patient was regularly followed-up. Six months later he was doing well with stable vital signs and no dyspnea or fever. The transthoracic echocardiogram at follow-up demonstrated a moderate tricuspid valve regurgitation.
Discussion
RSIE is rarer than left-sided involvement, accounting for around 5-10% of all cases of infective endocarditis [1] . It occurs predominantly in intravenous drug users and where intravenous devices (e.g., pacemakers, central venous catheters) are used. S. aureus is the most common microbiological organism. Other pathogenic bacteria of RSIE are streptococci [3, 4] .
S. agalactiae is a b-hemolytic Gram-positive bacterium [5] . It colonizes the female genitourinary tract, throat, and rectum of some humans [5] . It was first identified as the major cause of bovine endocarditis [9] . Later, it was described as a human pathogen that principally caused sepsis and meningitis in neonates, and could lead to death or long-term sequelae [6] . The susceptibility of infants and women who are pregnant and after obstetrical intervention to GBS disease depends on the level of capsular-type-specific antibodies in maternal serum [10] . Recently, the incidence of the GBS invasive infections in adults who are not pregnant is increasing [7] . In fact, a two to four-fold increase in the incidence of invasive GBS disease in adults has been reported during the past two decades; most infections are unrelated to pregnancy and occur in adults aged P65 years [7, 11] . The pathogenesis of GBS invasive disease in the elderly is multifactorial and is still poorly understood. It has been established that complement receptors present in neutrophils play a specific role in the susceptibility to the GBS disease. The chronic underlying diseases such as diabetes mellitus, malignancy, cardiac, gastrointestinal diseases, and neurological impairment frequent in elderly adults compromise the mechanisms of host-defense and alter the function of the neutrophils [10] . In addition, the reduced physical capacity, altered integrity of anatomical barriers in the elderly, and intrinsic virulence of S. agalactiae due to specific capsular polysaccharides of the GBS may contribute to the occurrence of GBS invasive infections in the elderly [12] . Despite the recent increase in GBS invasive disease, infective endocarditis remains uncommon (3% of clinical manifestations of invasive GBS infections) [7] . S. agalactiae-infective endocarditis is a very aggres-sive clinical entity characterized by acute onset, large vegetations, and severe valve mutilations and reaches old patients with chronic underlying diseases, mostly rheumatic heart disease [5] . The mitral and aortic valves are the most involved (77% of all cases) [5] .
S. agalactiae RSIE is very rare and involves either drug users, pregnant women, and elderly adults [13] . Only 24 cases of GBS infective endocarditis involving the tricuspid valve have been reported in the literature [14] [15] [16] [17] ; our case is the 25th to be described (Table 1) [5, 8, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .
Only seven patients were intravenous drug abusers and four had underlying chronic diseases. Most patients (19 of 24) were female and infective endocarditis occurred after obstetrical intervention in 10 of them [16, 17] . The clinical presentation was severe with acute onset, large vegetation, and tricuspid valve mutilation in most patients (88%). Seventeen patients presented pulmonary embolism. The antibiotic of choice was an association of penicillin and aminoglycoside [13] . Surgical treatment were indicated in seven cases and consisted in valve excision and replacement with a bioprothesis or tricuspid annuloplasty according to valve anatomy. All patients who underwent surgery had a good evolution [15] [16] [17] . Five patients who received only medical treatment died (29.4%) [16] . Our patient was the oldest described in the literature. He had no debilitating disease and did not consume any illicit drugs. In our patient, surgical treatment was indicated because of ongoing infection, increasing size of tricuspid vegetation, occurrence of pulmonary embolism, and right heart failure despite adapted antibiotics. The indication of surgery in GBS RSIE is less established than in left-sided endocarditis [8, 13] . The mortality in GBS tricuspid valve endocarditis is also lower than the left-sided endocarditis in which mortality rate can reach 50-100% if medical treatment only [5, 8, 18] . These data suggest that a combined medical-surgical treatment with early surgery could be the strategy of choice when S. agalactiae is responsible of the infection. Because of the frequent association with predisposing conditions and comorbidities, a close follow-up of our patient is necessary in order to detect on time a possible underlying malignancy that may be revealed by GBS tricuspid infective endocarditis.
Conclusion
GBS infective endocarditis is an aggressive clinical entity. Tricuspid valve involvement is rare and frequently occurs in postpartum and older patients with debilitating diseases. Because of the high probability of valve mutilation, severe complications, and poor prognosis, an appropriate medical-surgical approach seems to be the strategy of choice in this infection.
